Dalteparin in Combination With Sunitinib in Patients With Metastatic Kidney Cancer

Sponsor and Collaborators
Roswell Park Cancer Institute
Pfizer

Contact
AskRPCI 1-877-275-7724
AskRPCI@roswellpark.org

Principal Investigator
Roberto Pili, MD
Roswell Park Cancer Institute


Continue Reading

ClinicalTrials.gov Identifier
NCT01061411